Free Trial

SI-BONE Q1 2024 Earnings Report

SI-BONE logo
$17.29 +0.60 (+3.59%)
As of 04:00 PM Eastern

SI-BONE EPS Results

Actual EPS
-$0.27
Consensus EPS
-$0.29
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A

SI-BONE Revenue Results

Actual Revenue
$37.87 million
Expected Revenue
$36.45 million
Beat/Miss
Beat by +$1.42 million
YoY Revenue Growth
N/A

SI-BONE Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

SI-BONE Earnings Headlines

SI-Bone price target raised to $20 from $19 at Needham
A simple pattern that works in any market
Right when most traders were getting bearish, The All-Weather Pattern signaled something different. Following this setup could've turned every $1,000 into $1,770 in just 48 hours. But here's what really gets me excited... You don't need to be glued to your screen all day, no complex formulas, no guessing. Just wait for a stock to close below The All-Weather Pattern, then check if it opens higher the next morning. That's it. While of course I cannot promise future returns or against losses… I've put together a complete breakdown of how this works, including the new stock that’s tending towards The All-Weather Pattern this week.
SI-Bone’s Robust Growth and Market Potential Justify Buy Rating
Truist Financial Keeps Their Buy Rating on SI-Bone (SIBN)
See More SI-BONE Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SI-BONE? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SI-BONE and other key companies, straight to your email.

About SI-BONE

SI-BONE (NASDAQ:SIBN), a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

View SI-BONE Profile

More Earnings Resources from MarketBeat